SF3B1 and mesothelioma: The IC50 values observed after treatment with our most promising compounds were however higher than what has been reported for PB and E7107 in different preclinical models of solid tumours, such as mesothelioma, where IC50 values of these SF3B1 modulators are in the nanomolar range[54].